Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block

Encyclopedia of pharmaceutical technology

Choice Reviews Online · 2003 · 1.7K citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutical Biotechnology +12

Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development

Lajos Szente · Advanced Drug Delivery Reviews · 1999 · 533 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Cyclodextrin-based controlled drug release system

Fumitoshi Hirayama · Advanced Drug Delivery Reviews · 1999 · 491 citations

Pharmacy, Pharmaceutics, Pharmacology +12

A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host The discovery of Org 25969 is the result of teamwork with contributions from a number of scientists both inside Organon and outside the company. We would like in particular to acknowledge the following scientists for their invaluable contributions: E. Hutchinson, D. Stevenson, R. Roy, and J. Pick for scaling-up the synthesis; F. Hope, S. Miller, and R. Mason for various in vitro and in vivo pharmacological testing; R. Watson, B. Montgomery, P. Desmond, and A. Osprey for all their analytical effort; and R. McGuire and J. Mestres for graphical presentation of the X-ray crystal structure of the Org 25969–rocuronium complex (Figure 3). We would also like to thank Prof. A. Cooper of Glasgow University who has critically reproduced our calorimetry data of Org 25969–rocuronium complexation (Figure 2).

A. Bom, Mark Philip Bradley, Ken Cameron et al. · Angewandte Chemie International Edition · 2002 · 457 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide

Francois Gijsenbergh, Steven Ramael, Natalie Houwing et al. · Anesthesiology · 2005 · 310 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15